Finance

Beta
Senarai
Sektor ekuiti
Simbol
Simbol
Harga
Perubahan
% Perubahan
Arah aliran
Ditutup sebelum ini
Buka
Tinggi
Rendah
Volum
Permodalan Pasaran
SIXB
Materials
SIXB
Materials
SIXB
-1.41%
1,076.13
-15.38
-1.41%
—1,091.511,090.401,090.401,073.69——
SIXC
Communications
SIXC
Communications
SIXC
-0.55%
606.74
-3.37
-0.55%
—610.11610.11610.29606.17——
SIXE
Energy
SIXE
Energy
SIXE
+0.88%
1,248.82
+10.84
+0.88%
—1,237.981,237.831,252.411,225.03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.17%
1,724.36
-20.35
-1.17%
—1,744.711,740.951,747.291,721.57——
SIXM
Financials
SIXM
Financials
SIXM
-0.72%
635.59
-4.59
-0.72%
—640.18639.92643.19634.73——
SIXR
Staples
SIXR
Staples
SIXR
-0.76%
843.15
-6.43
-0.76%
—849.58845.27851.68839.47——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.55%
216.29
-1.19
-0.55%
—217.48217.48218.16215.51——
SIXT
Technology
SIXT
Technology
SIXT
+0.08%
3,263.41
+2.72
+0.08%
—3,260.693,273.363,287.813,240.78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.34%
939.24
-3.21
-0.34%
—942.45939.39948.80933.98——
SIXV
Health care
SIXV
Health care
SIXV
-0.29%
1,462.56
-4.24
-0.29%
—1,466.801,464.701,467.191,458.36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.71%
2,380.40
-17.10
-0.71%
—2,397.502,395.032,412.012,370.64——
BIIB:VIE
Biogen Inc
€159.96
-1.93%
(-3.14) 1H
4 Mei, 5:36:00 PTG GMT+2  ·   EUR
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk BIIB...
Buka
€159.94
Tinggi
€160.52
Rendah
€158.84
Permodalan Pasaran
27.64B
Purata volum
20.00
Volum
0.00
tgi 52 mgu
€170.00
rdh 52 mgu
€102.40
Syer tertunggak
201.48J
Bilangan pekerja
8K
Cerita berita
Daripada sumber merentas web
Profil
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases. The company's primary products are dimethyl fumarate, diroximel fumarate, interferon beta-1a, peginterferon beta-1a, and natalizumab, all for the treatment of multiple sclerosis; nusinersen for the treatment of spinal muscular atrophy; omaveloxolone for the treatment of Friedreich's ataxia; tofersen for the treatment of ALS; and dimethyl fumarate for the treatment of severe plaque psoriasis. The company also produces 5 biosimilars and has collaborations with Genentech for several drugs. The company is ranked 424th on the Fortune 500 and 845th on the Forbes Global 2000. Wikipedia
Perihal Biogen Inc
CEOChris Viehbacher
Pekerja7.5K
Diasaskan1978
Ibu pejabatCambridge, Massachusetts, Amerika Syarikat
Sektor-
Laman webbiogen.com
Laporan sebelumnyaSemua nilai dalam USD
Loading Previous Earnings...
Penyata pendapatan
Hasil
Pendapatan bersih
Semua nilai dalam USD
Jun 2025
Sep 2025
Dis 2025
Mac 2026
Hasil
2.65B
2.53B
2.28B
2.48B
Kos barangan yang dijual
946.20J
508.60J
443.40J
610.20J
Kos hasil
946.20J
508.60J
443.40J
610.20J
Perbelanjaan penyelidikan dan pembangunan
-
431.80J
501.00J
482.20J
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
581.30J
592.80J
685.20J
607.30J
Belanja kendalian
783.70J
1.25B
1.39B
1.30B
Jumlah belanja kendalian
1.73B
1.76B
1.83B
1.91B
Pendapatan kendalian
915.60J
778.60J
447.70J
567.40J
Pendapatan bukan kendalian lain
-3.30J
15.80J
17.40J
-1.10J
EBT termasuk item luar biasa
744.00J
557.30J
-56.00J
377.70J
EBT tidak termasuk item luar biasa
861.60J
748.30J
423.10J
530.10J
Belanja cukai pendapatan
109.20J
90.80J
-7.10J
58.20J
Kadar cukai berkesan
14.68%
16.29%
12.68%
15.41%
Belanja kendalian lain
75.00J
87.20J
69.90J
74.20J
Pendapatan bersih
634.80J
466.50J
-48.90J
319.50J
Margin untung bersih
24.00%
18.40%
-2.15%
12.89%
Perolehan bagi setiap syer
5.47
4.81
1.99
3.57
Pendapatan faedah dan pelaburan
32.30J
31.60J
37.20J
37.90J
Belanja faedah
-72.60J
-67.40J
-67.50J
-67.60J
Belanja faedah bersih
-40.30J
-35.80J
-30.30J
-29.70J
Caj susut nilai dan pelunasan
-
-
-
-
EBITDA
1.11B
980.80J
647.90J
771.80J
Keuntungan atau kerugian daripada jualan aset
-
-
-
-
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian

Penyelidikan

Tugasan saya
Anda belum membuat tugasan lagi
Tugasan anda akan dipaparkan di sini. Jadualkan tugasan dan manfaatkan Google Finance semasa anda tiada.
Templat
Ringkasan senarai amatan
Analisis prapasaran harian bagi senarai amatan anda
Pendapatan Akan Datang
Laporan pendapatan akan datang dalam minggu ini
Kemudahubahan & Jumlah yang Tidak Normal
Amaran awal kemudahubahan dan jumlah hari ini
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian